Literature DB >> 24576675

LRRK2, but not pathogenic mutants, protects against H2O2 stress depending on mitochondrial function and endocytosis in a yeast model.

Clara Pereira1, L Miguel Martins2, Lucília Saraiva3.   

Abstract

BACKGROUND: Mutations in LRRK2 are the most common genetic cause of Parkinson's disease (PD). Studies in the yeast Saccharomyces cerevisiae have provided valuable insights into the mechanisms of cellular dysfunction associated with the expression of faulty PD genes.
METHODS: We developed a yeast model for full-length LRRK2 studies. We expressed wild-type (wt) LRRK2 and mutations and evaluated their role during oxidative stress conditions. The involvement of mitochondria was assessed by using rho-zero mutants and by evaluating reactive oxygen species (ROS) production and mitochondrial membrane potential by flow cytometry. The involvement of endocytosis was also studied by testing several endocytic mutants and by following the vacuolar delivery of the probe FM4-64.
RESULTS: Expression of LRRK2 in yeast was associated to increased hydrogen peroxide resistance. This phenotype, which was dependent on mitochondrial function, was not observed for PD-mutants G2019S and R1441C or in the absence of the kinase activity and the WD40 repeat domain. Expression of the pathogenic mutants stimulated ROS production and increased mitochondrial membrane potential. For the PD-mutants, but not for wild-type LRRK2, endocytic defects were also observed. Additionally, several endocytic proteins were required for LRRK2-mediated protection against hydrogen peroxide.
CONCLUSIONS: Our results indicate that LRRK2 confers cellular protection during oxidative stress depending on mitochondrial function and endocytosis. GENERAL SIGNIFICANCE: Both the loss of capacity of LRRK2 pathogenic mutants to protect against oxidative stress and their enhancement of dysfunction may be important for the development of PD during the aging process.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cellular dysfunction; LRRK2; Oxidative stress; Parkinson's disease; Saccharomyces cerevisiae

Mesh:

Substances:

Year:  2014        PMID: 24576675     DOI: 10.1016/j.bbagen.2014.02.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Neuroprotective Effect of the LRRK2 Kinase Inhibitor PF-06447475 in Human Nerve-Like Differentiated Cells Exposed to Oxidative Stress Stimuli: Implications for Parkinson's Disease.

Authors:  Miguel Mendivil-Perez; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio
Journal:  Neurochem Res       Date:  2016-07-09       Impact factor: 3.996

2.  Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils.

Authors:  Isabella Russo; Alice Kaganovich; Jinhui Ding; Natalie Landeck; Adamantios Mamais; Tatiana Varanita; Alice Biosa; Isabella Tessari; Luigi Bubacco; Elisa Greggio; Mark R Cookson
Journal:  Neurobiol Dis       Date:  2019-05-15       Impact factor: 5.996

3.  LRRK2 and mitochondria: Recent advances and current views.

Authors:  Alpana Singh; Lianteng Zhi; Hui Zhang
Journal:  Brain Res       Date:  2018-06-09       Impact factor: 3.252

Review 4.  Effect of cadmium on essential metals and their impact on lipid metabolism in Saccharomyces cerevisiae.

Authors:  Selvaraj Rajakumar; Albert Abhishek; Govindan Sadasivam Selvam; Vasanthi Nachiappan
Journal:  Cell Stress Chaperones       Date:  2019-12-10       Impact factor: 3.667

Review 5.  Two-Pore Domain Potassium Channel in Neurological Disorders.

Authors:  Punita Aggarwal; Sanjiv Singh; V Ravichandiran
Journal:  J Membr Biol       Date:  2021-06-24       Impact factor: 1.843

Review 6.  The role of the LRRK2 gene in Parkinsonism.

Authors:  Jie-Qiong Li; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurodegener       Date:  2014-11-12       Impact factor: 14.195

Review 7.  From the baker to the bedside: yeast models of Parkinson's disease.

Authors:  Regina Menezes; Sandra Tenreiro; Diana Macedo; Cláudia N Santos; Tiago F Outeiro
Journal:  Microb Cell       Date:  2015-07-27

8.  Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson's Disease-Associated LRRK2 Gene Mutations.

Authors:  David A Loeffler; Andrea C Klaver; Mary P Coffey; Jan O Aasly; Peter A LeWitt
Journal:  Front Aging Neurosci       Date:  2017-04-03       Impact factor: 5.750

Review 9.  The Function of the Mitochondrial Calcium Uniporter in Neurodegenerative Disorders.

Authors:  Yajin Liao; Yuan Dong; Jinbo Cheng
Journal:  Int J Mol Sci       Date:  2017-02-10       Impact factor: 5.923

Review 10.  What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?

Authors:  David A Loeffler; Jan O Aasly; Peter A LeWitt; Mary P Coffey
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.